1Richards AM, Nicholls MG, Yandle TG, et al. Plasma N terminal probrain natriuretic peptide and adrenomedullin : new neurohormonal predictors of left ventricular dysfunction and prognosis after myocardial infarction[J]. Circulation, 1998, 97 : 1921-9.
2Remme WJ,Swdberg K. Guidelines for the diagnosis and treatment of chronic heart failure: Task force report[J]. Eur Heart J,2001, 22 : 1527-60.
3Clerico A, Iervasi G, Chicca M, et al. Circulating levels of cardiac natriuretic peptides(ANP and BNP)measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patientswith different degrees of heart failure. J Endocrinol Invest, 1998,21 : 170-9.
4Silver MA, Maisel A, Yancy CW, et al. BNP Consensus Panel 2004 : A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptidesin cardiovascular diseases. Congest Heart Fail, 2004, 10(suppl 3) : 1-30.
5Pandey KN.Biology of natriuretic peptides and their re-ceptors. Peptides . 2005
6Daniels LB,Clopton P,Bhalla V,et al.How obesity af-fects the cut-points for B-type natriuretic peptide in thediagnosis of acute heart failure.Results from the Breath-ing Not Properly Multinational Study. American Heart Journal . 2006
7Mecullough PA,Omlandt,Maisel AS.B-type natriure-tie PePtides:a Diagnostc breakthrough for clinieals. Reviews in Cardiovascular Medicine . 2003
9Lainchbury JG,Nicolls MG,Espiner EAet al.Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man. lin Sci . 1998
10Lapointe MC.Molecular regulation of the brain natriuretic peptide gene. Peptides . 2005
